Print

Transcept Pharmaceuticals, Inc. Inks $145 Million Sleep Drug Deal with Purdue Pharmaceutical Products LP  
8/4/2009 7:04:36 AM

Bookmark and Share

Bizjournals.com -- Purdue Pharmaceutical Products LP will market Transcept Pharmaceuticals Inc.’s middle-of-the-night sleep drug, Intermezzo. Now Transcept just needs to win FDA approval of the drug.

//-->